Research Participants

Subjects come first for the BRANY Institutional Review Board (IRB). We are dedicated to protecting the rights and ensuring the welfare of all human research subjects, as evidenced by our commitment to ethical research and rigorous research oversight.

This section of our website provides current and potential research participants with useful information about participating in clinical trials, the protections they are entitled to, and a method to provide feedback and concerns about specific clinical trials.

 


Search Trials


Our Newest Trials

PROCADE prostate cancer

COSTAR Lung 213410 Prior Anti-Pd-(L)1 Therapy with Platinum Chemotherapy

COSTAR Lung 213410 Prior Anti-Pd-(L)1 Therapy with Platinum Chemotherapy

Breast Cancer DESTINY-05

Advanced Solid Tumors with KRAS G12C Mutation

PROSTATE CANCER De Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Non-Small Cell Lung Cancer NSCLC Prior Anti-Pd-(L)1 Therapy with Chemotherapy

Long Lasting Lenacapavir HIV

Abbvie - Myelofibrosis - M16 -191

Primary Biliary Cholangitis (PBC) Assure